Jim Greenwood is a former house parent and caseworker helping disabled and abused children. At the age of 29 he was elected to the Pennsylvania House of Representatives where he formed the Legislative Children’s Caucus. After six years in the State House he was elected to the State Senate and six years later to Congress.
During his 12 years in Congress Greenwood was a leader on healthcare, reproductive rights and environmental issues, and as Chair of the Energy and Commerce Committee Subcommittee on Oversight and Investigation, he led investigations into Enron, Global Crossings, WorldCom, Imclone, nuclear waste cleanup and government waste fraud and abuse. From 2005 through 2020 Greenwood served as the President and CEO of the Biotechnology Innovation Organization and grew it into a world-class trade association for more than 1,000 biopharmaceutical companies. He currently chairs the Life Sciences Health, Policy and Regulatory Group at the DLA Piper law firm and serves as an advisor to RA Capital.
Life Science Builders agree that society's payments for branded drugs must be a finite mortgage, oppose the rent extraction that is on the rise in the drug industry today, and stand with us in calling on Congress to pass Contractual Genericization.Read more